Stock Screener App

無料 - Play StoreApp Store

インストールインストール

Dow:

Nasdaq:

S&P 500:

RVMD

$188.201.63%-3.11

アフターアワーズ： 188.17-0.03 -0.02%

Revolution Medicines Inc (RVMD)

Date: O: H: L: C: Vol:

Revolution Medicines Inc (RVMD) 最新ニュース

Revolution Medicines officer sells $431,946 in shares By Investing.com - Investing.com South Africa

Should You Buy Royalty Pharma Stock Before Nov. 4? - The Motley Fool

Could Revolution Medicines Be a Millionaire-Maker Stock? - The Motley Fool

Could Revolution Medicines Be a Millionaire-Maker Stock? - Yahoo Finance

Could Revolution Medicines Be a Millionaire-Maker Stock? - The Motley Fool

Anthony Mancini Executes and Sells 2,310 Shares at $186.99 Under 10b5-1 Plan at Revolution Medicines - Kalkine Media

Form 4 Revolution Medicines Inc: Anthony Mancini (Officer) For: 26 October - Investing.com Nigeria

Form 4 Revolution Medicines Inc: Anthony Mancini (Officer) For: 26 October - Investing.com UK

Revolution Medicines officer sells $431,946 in shares By Investing.com - Investing.com UK

Revolution Medicines (RVMD) officer exercised options at $33.62 and sold shares at $186.99. - Stock Titan

Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement - Yahoo Finance

Billionaire Stanley Druckenmiller Added to Revolution Medicines Before Its FDA Win. Is the Stock Still a Buy After a 134% Run? - The Motley Fool

Billionaire Stanley Druckenmiller Added to Revolution Medicines Before Its FDA Win. Is the Stock Still a Buy After a 134% Run? - The Motley Fool

Boeing Stock Drops 7.5% After Q3 Earnings Miss Erases $10 Billion - 24/7 Wall St.

Revolution Medicines director sells $1.96 million of stock - Investing.com

Form 4 Revolution Medicines Inc: Elizabeth M. Anderson (Director) For: 22 September By Investing.com - Investing.com India

Revolution Medicines director sells $1.96 million of stock By Investing.com - Investing.com India

Colorectal Cancer Market Set for Significant Growth During the Forecast Period (2026–2036), Due to the Emergence of Emerging Targets such as KRAS G12C, NTRK Fusions, and PIK3CA Mutations | DelveInsight - GlobeNewswire Inc.

UBS reiterates Buy on Revolution stock, keeps $265 price target By Investing.com - Investing.com Canada

Should JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (BBMC) Be on Your Investing Radar? - Yahoo Finance

Form 144 REVOLUTION MEDICINES INC For: 25 October By Investing.com - Investing.com India

Form 144 REVOLUTION MEDICINES INC For: 25 October By Investing.com - Investing.com UK

Revolution Medicines presents subgroup data from pancreatic cancer trial By Investing.com - Investing.com Canada

Revolution Medicines Reports RASONQUE Shows Consistent Overall Survival Benefit Across Key Subgroups in Phase 3 RASolute 302 Trial - Quiver Quantitative

Can Tango Therapeutics (NASDAQ:TNGX) Redefine Cancer Care? - Kalkine Media

Tamar Securities - Trusted Asset Management - FinancialContent

Revolution Medicines (RVMD) Has an Approved Cancer Drug. Can Its $38 Billion Valuation Deliver? - Insider Monkey

RVMD Stock Rallies As RASONQUE Launch Momentum Accelerates - Timothy Sykes

These 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside Ahead - The Motley Fool

About 3% of U.S. patients with metastatic pancreatic cancer survive five years. A drug pair starts testing in patients. - Stock Titan

Revolution Medicines (NasdaqGS:RVMD) Stock Forecast & Analyst Predictions - Simply Wall Street

Revolution Medicines’ CDO Sandler sells $1.2m in stock - Investing.com

Form 4 Revolution Medicines Inc For: 1 October By Investing.com - Investing.com UK

Form 4 Revolution Medicines Inc For: 1 October By Investing.com - Investing.com Canada

Revolution Medicines SVP Cislini sells $158,599 in shares By Investing.com - Investing.com Nigeria

Form 4 Revolution Medicines Inc For: 29 September By Investing.com - Investing.com South Africa

Revolution Medicines SVP Cislini sells $158,599 in shares - Investing.com

Form 4 Revolution Medicines Inc For: 29 September By Investing.com - Investing.com UK

Revolution Medicines SVP Jeff Cislini Sells 765 Shares Under 10b5-1 Trading Plan - Kalkine Media

Revolution Medicines (RVMD) counsel Jeff Cislini sold 765 shares at $207.3201 each under a trading plan. - Stock Titan

6,000 shares from exercised options are listed for an officer’s proposed sale at Revolution Medicines (RVMD). - Stock Titan

Form 4 Revolution Medicines Inc For: 28 September By Investing.com - Investing.com South Africa

Form 4 Revolution Medicines Inc For: 28 September By Investing.com - Investing.com Nigeria

Revolution Medicines officer Mancini sells $743k in stock - Investing.com

Form 4 Revolution Medicines Inc For: 28 September By Investing.com - Investing.com UK

Stock options are the source of 9,363 shares a Revolution Medicines (RVMD) officer proposes to sell. - Stock Titan

Revolution Medicines director Elizabeth Anderson sells $1.96m in stock - Investing.com

Revolution Medicines (RVMD) director exercises options for 5,070 shares and sells 10,143 shares. - Stock Titan

After three earlier sales, an officer proposes selling 587 more Revolution Medicines (RVMD) shares. - Stock Titan

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes - Yahoo Finance

RVMDに類似

ONC$361.202.47%

GMAB$54.933.73%

RPRX$66.520.98%

ROIV$35.892.76%

ARGX$875.141.99%

INCY$120.060.27%